ACER THERAPEUTICS INC.: cash_and_equivalents
| Value | {"amount": 13637419, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2014-09-30) |
| Status | current |
| Entity | ACER THERAPEUTICS INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:35:21.574772+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/4489fc1f-3dd4-4e66-8eae-896be523fc05
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001157523-14-004456 · Open the official SEC filing →Retrieved: 2026-08-19T10:35:21.574772+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001069308/cash-and-equivalents/2014-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/4489fc1f-3dd4-4e66-8eae-896be523fc05
History
- no predecessors — first report